PacBio Raises $109M in Series F Financing Round; Wins NHGRI Grant for Direct Transcriptome Sequencing
July 20, 2010
PacBio Raises $109M in Series F Financing Round; Wins NHGRI Grant for Direct Transcriptome Sequencing
The company recently started shipping instruments to early-access customers. It will use the new funding to support the upcoming commercial launch of its PacBio RS system.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- PacBio Reveals Beta System Specs for RS; Says Commercial Release is on Track for First Half of 2011
December 7, 2010 / In Sequence - Launch of PacBio RS Drives Q2 Revenue, but Investors Raise Concerns Over Pace of Uptake
August 9, 2011 / In Sequence - PacBio Ships First Two Commercial Systems; Order Backlog Grows to 44
May 3, 2011 / In Sequence - PacBio Grows Order Backlog in Q4; Sees Increased Interest in Microbial Sequencing
February 22, 2011 / In Sequence - USPTO Board Rules on PacBio, Life Tech Patent Interference Case
February 1, 2011 / In Sequence